Androgen Deprivation Therapy in Prostate Cancer: Looking Beyond Prostate-specific Antigen and Testosterone Levels

被引：4
|
作者：
Saad, Fred [1 ]
机构：
[1] Univ Montreal, Ctr Hosp, Montreal, PQ H2L 4M1, Canada
来源：
EUROPEAN UROLOGY | 2015年 / 67卷 / 05期
关键词：
D O I：
10.1016/j.eururo.2014.08.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：837 / 838
页数：2
相关论文
共 50 条
  • [41] Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes
    Xu, JF
    Meyers, DA
    Sterling, DA
    Zheng, SQL
    Catalona, WJ
    Cramer, SD
    Bleecker, ER
    Ohar, J
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (07) : 664 - 669
  • [42] Elevated serum chromogranin A precedes prostate-specific antigen elevation and predicts failure of androgen deprivation therapy in patients with advanced prostate cancer
    Chuang, CK
    Wu, TL
    Tsao, KC
    Liao, SK
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2003, 102 (07) : 480 - 485
  • [43] Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation Therapy
    Lin, Yen-Chi
    Lin, Po-Hung
    Shao, I-Hung
    Chu, Yuan-Cheng
    Kan, Hung-Cheng
    Liu, Chung-Yi
    Yu, Kai-Jie
    Chang, Ying-Hsu
    Pang, See-Tong
    Huang, Jhen-Ling
    Chuang, Cheng-Keng
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021
  • [44] Rapid time to prostate-specific antigen nadir after androgen deprivation therapy is associated with vitamin d deficiency in prostate cancer patients
    Amadi, C.
    Amadi, B. C.
    Odum, E. P.
    Okafor, J. C.
    [J]. CLINICA CHIMICA ACTA, 2024, 558 : 52 - 52
  • [45] Prostate-specific antigen and prostate cancer
    Rosalki, SB
    Rutherford, FJ
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (09) : 611 - 613
  • [46] Prostate-specific membrane antigen radioligand therapy of prostate cancer
    Beheshti, Mohsen
    Heinzel, Alexander
    von Mallek, Dirk
    Filss, Christian
    Mottaghy, Felix M.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (01): : 29 - 36
  • [47] EXAMINING TESTOSTERONE RECOVERY IN ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
    Preston, Mark A.
    Marden, Jessica R.
    Kirson, Noam
    Nwokeji, Esmond
    Gandhi, Raj
    Briggs, Allison
    Gaburo, Katherine
    Hanson, Sarah
    Morgans, Alicia K.
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E491 - E491
  • [48] BIOMARKERS FOR PROSTATE CANCER DETECTION AND, PROGRESSION: BEYOND PROSTATE-SPECIFIC ANTIGEN
    Berney, Daniel M.
    [J]. DRUG NEWS & PERSPECTIVES, 2010, 23 (03) : 185 - 194
  • [49] IS PROSTATE-SPECIFIC ANTIGEN DENSITY MORE USEFUL THAN PROSTATE-SPECIFIC ANTIGEN LEVELS IN THE DIAGNOSIS OF PROSTATE-CANCER
    OHORI, M
    DUNN, JK
    SCARDINO, PT
    [J]. UROLOGY, 1995, 46 (05) : 666 - 671
  • [50] Changes in prostate-specific antigen and hormone levels following withdrawal of prolonged androgen ablation for prostate cancer
    S Egawa
    H Okusa
    K Matsumoto
    K Suyama
    S Baba
    [J]. Prostate Cancer and Prostatic Diseases, 2003, 6 : 245 - 249
12345